|
Single muscle assessment for diagnosing sarcopenia is inherently flawed.
|
J Stroke Cerebrovasc Dis
38242814
|
0 |
2.5 |
2024 |
|
Revisiting the obesity paradox in heart failure: what is the best anthropometric index to gauge obesity?
|
Eur Heart J
36944505
|
1 |
39.3 |
2023 |
|
Response by Schulze et al to Letter Regarding Article, "Effects of Early Empagliflozin Initiation on Diuresis and Kidney Function in Patients With Acute Decompensated Heart Failure (EMPAG-HF)".
|
Circulation
36745697
|
0 |
37.8 |
2023 |
|
Understanding Who Responds to M-TEER in Heart Failure With SMR: Malnutrition Does Not Preclude Benefit.
|
J Am Coll Cardiol
37407112
|
0 |
24 |
2023 |
|
Clinical and Prognostic Relevance of Cardiac Wasting in Patients With Advanced Cancer.
|
J Am Coll Cardiol
37076211
|
1 |
24 |
2023 |
|
Patient phenotype profiling in heart failure with preserved ejection fraction to guide therapeutic decision making. A scientific statement of the Heart Failure Association, the European Heart Rhythm Association of the European Society of Cardiology, and the European Society of Hypertension.
|
Eur J Heart Fail
37461163
|
2 |
18.2 |
2023 |
|
Impact of anaemia and iron deficiency on outcomes in cardiogenic shock complicating acute myocardial infarction.
|
Eur J Heart Fail
38084483
|
0 |
18.2 |
2023 |
|
Cardiovascular health-related quality of life in cancer: a prospective study comparing the ESC HeartQoL and EORTC QLQ-C30 questionnaire.
|
Eur J Heart Fail
37369985
|
0 |
18.2 |
2023 |
|
Effect of intravenous iron replacement on recurrent heart failure hospitalizations and cardiovascular mortality in patients with heart failure and iron deficiency: A Bayesian meta-analysis.
|
Eur J Heart Fail
37062867
|
3 |
18.2 |
2023 |
|
Little at a time: trying to understand the battery of benefits of sodium-glucose contransporter 2 inhibitors in heart failure.
|
Eur J Heart Fail
36597825
|
0 |
18.2 |
2023 |
|
Pre-discharge and early post-discharge management of patients hospitalized for acute heart failure: A scientific statement by the Heart Failure Association of the ESC.
|
Eur J Heart Fail
37448210
|
1 |
18.2 |
2023 |
|
The small molecule ACM-001 improves cardiac function in a rat model of severe cancer cachexia.
|
Eur J Heart Fail
36999379
|
1 |
18.2 |
2023 |
|
Bone status in men with heart failure: results from the Studies Investigating Co-morbidities Aggravating Heart Failure.
|
Eur J Heart Fail
36781201
|
0 |
18.2 |
2023 |
|
Supervised exercise training in patients with advanced heart failure and left ventricular assist device: A multicentre randomized controlled trial (Ex-VAD trial).
|
Eur J Heart Fail
37702315
|
0 |
18.2 |
2023 |
|
Worsening of chronic heart failure: definition, epidemiology, management and prevention. A clinical consensus statement by the Heart Failure Association of the European Society of Cardiology.
|
Eur J Heart Fail
37208936
|
3 |
18.2 |
2023 |
|
Impact of ferric carboxymaltose for iron deficiency at discharge after heart failure hospitalization: a European multinational economic evaluation.
|
Eur J Heart Fail
36718652
|
1 |
18.2 |
2023 |
|
Patient-reported ability to walk 4 m and to wash: New clinical endpoints and predictors of survival in patients with pre-terminal cancer.
|
J Cachexia Sarcopenia Muscle
37222009
|
1 |
8.9 |
2023 |
|
Hand grip strength in patients with advanced cancer: A prospective study.
|
J Cachexia Sarcopenia Muscle
37318103
|
1 |
8.9 |
2023 |
|
Kidney function in cachexia and sarcopenia: Facts and numbers.
|
J Cachexia Sarcopenia Muscle
37222019
|
0 |
8.9 |
2023 |
|
Diagnosis and outcomes of cachexia in Asia: Working Consensus Report from the Asian Working Group for Cachexia.
|
J Cachexia Sarcopenia Muscle
37667992
|
1 |
8.9 |
2023 |
|
Effects of a 2-year exercise training on neuromuscular system health in older individuals with low muscle function.
|
J Cachexia Sarcopenia Muscle
36708273
|
1 |
8.9 |
2023 |
|
Ethical guidelines for publishing in the Journal of Cachexia, Sarcopenia and Muscle: Update 2023.
|
J Cachexia Sarcopenia Muscle
38148513
|
0 |
8.9 |
2023 |
|
Extent of Abdominal Aortic Calcification Is Associated With Incident Rapid Weight Loss Over 5 Years: PLSAW.
|
Arterioscler Thromb Vasc Biol
38095109
|
0 |
8.7 |
2023 |
|
Role of Copeptin and hs-cTnT to Discriminate AHF from Uncomplicated NSTE-ACS with Baseline Elevated hs-cTnT-A Derivation and External Validation Study.
|
Cells
37048135
|
0 |
6 |
2023 |
|
The treatment of chronic anemia in heart failure: a global approach.
|
Clin Res Cardiol
37660308
|
0 |
5 |
2023 |
|
Efficacy and safety of intravenous iron repletion in patients with heart failure: a systematic review and meta-analysis.
|
Clin Res Cardiol
37074386
|
1 |
5 |
2023 |
|
Predictors of lower exercise capacity in patients with cancer.
|
Sci Rep
37684302
|
0 |
4.6 |
2023 |
|
Aortic valve calcification and myocardial fibrosis determine outcome following transcatheter aortic valve replacement.
|
ESC Heart Fail
37060191
|
0 |
3.8 |
2023 |
|
The role of nutraceuticals in heart failure muscle wasting as a result of inflammatory activity. The International Lipid Expert Panel (ILEP) Position Paper.
|
Arch Med Sci
37560745
|
2 |
3.8 |
2023 |
|
A year in heart failure: updates of clinical and preclinical findings.
|
ESC Heart Fail
37072681
|
2 |
3.8 |
2023 |
|
Current advancements in pharmacotherapy for cancer cachexia.
|
Expert Opin Pharmacother
36995115
|
2 |
3.2 |
2023 |
|
Multicomponent intervention to prevent mobility disability in frail older adults: randomised controlled trial (SPRINTT project).
|
BMJ
35545258
|
31 |
105.7 |
2022 |
|
Travelling with heart failure: risk assessment and practical recommendations.
|
Nat Rev Cardiol
34992256
|
0 |
49.6 |
2022 |
|
Iron deficiency and cardiovascular disease.
|
Eur Heart J
36282723
|
11 |
39.3 |
2022 |
|
Effects of Early Empagliflozin Initiation on Diuresis and Kidney Function in Patients With Acute Decompensated Heart Failure (EMPAG-HF).
|
Circulation
35766022
|
16 |
37.8 |
2022 |
|
Preventing heart failure: a position paper of the Heart Failure Association in collaboration with the European Association of Preventive Cardiology.
|
Eur J Heart Fail
35083829
|
11 |
18.2 |
2022 |
|
Skeletal muscle derived Musclin protects the heart during pathological overload.
|
Nat Commun
35013221
|
13 |
16.6 |
2022 |
|
Iron deficiency is related to low functional outcome in patients at early rehabilitation after acute stroke.
|
J Cachexia Sarcopenia Muscle
35166066
|
6 |
8.9 |
2022 |
|
The atypical β-blocker S-oxprenolol reduces cachexia and improves survival in a rat cancer cachexia model.
|
J Cachexia Sarcopenia Muscle
36346141
|
1 |
8.9 |
2022 |
|
Furnishing the cachexia landscape: A year of research in JCSM.
|
J Cachexia Sarcopenia Muscle
36510825
|
0 |
8.9 |
2022 |
|
Step-by-step diagnosis and management of the nocebo/drucebo effect in statin-associated muscle symptoms patients: a position paper from the International Lipid Expert Panel (ILEP).
|
J Cachexia Sarcopenia Muscle
35969116
|
8 |
8.9 |
2022 |
|
The erythropoietin-derived peptide ARA 284 reduces tissue wasting and improves survival in a rat model of cancer cachexia.
|
J Cachexia Sarcopenia Muscle
35586884
|
0 |
8.9 |
2022 |
|
The beneficial therapeutic effects of plant-derived natural products for the treatment of sarcopenia.
|
J Cachexia Sarcopenia Muscle
35961944
|
8 |
8.9 |
2022 |
|
D -Creatine dilution for body composition assessment: A direct take on the matter.
|
J Cachexia Sarcopenia Muscle
36156465
|
1 |
8.9 |
2022 |
|
Birth weight and heart failure: hindsight as an exact science?
|
Eur J Prev Cardiol
35134156
|
0 |
8.3 |
2022 |
|
Preventing heart failure: a position paper of the Heart Failure Association in collaboration with the European Association of Preventive Cardiology.
|
Eur J Prev Cardiol
35083485
|
2 |
8.3 |
2022 |
|
Soluble ST2 Receptor: Biomarker of Left Ventricular Impairment and Functional Status in Patients with Inflammatory Cardiomyopathy.
|
Cells
35159224
|
2 |
6 |
2022 |
|
Metabolomic Profiling in Patients with Heart Failure and Exercise Intolerance: Kynurenine as a Potential Biomarker.
|
Cells
35626711
|
2 |
6 |
2022 |
|
Biomarkers-in-Cardiology 8 RE-VISITED-Consistent Safety of Early Discharge with a Dual Marker Strategy Combining a Normal hs-cTnT with a Normal Copeptin in Low-to-Intermediate Risk Patients with Suspected Acute Coronary Syndrome-A Secondary Analysis of the Randomized Biomarkers-in-Cardiology 8 Trial.
|
Cells
35053326
|
0 |
6 |
2022 |
|
Iron Deficiency and Reduced Muscle Strength in Patients with Acute and Chronic Ischemic Stroke.
|
J Clin Med
35160047
|
2 |
3.9 |
2022 |
|
Defining terms commonly used in sarcopenia research: a glossary proposed by the Global Leadership in Sarcopenia (GLIS) Steering Committee.
|
Eur Geriatr Med
36445639
|
7 |
3.8 |
2022 |
|
Cardiovascular and metabolic determinants of quality of life in patients with cancer.
|
ESC Heart Fail
36178215
|
0 |
3.8 |
2022 |
|
ACC/AHA/HFSA 2022 and ESC 2021 guidelines on heart failure comparison.
|
ESC Heart Fail
36460629
|
0 |
3.8 |
2022 |
|
Heart failure: an update from the last years and a look at the near future.
|
ESC Heart Fail
36546712
|
2 |
3.8 |
2022 |
|
Cardiovascular magnetic resonance imaging patterns of acute COVID-19 mRNA vaccine-associated myocarditis in young male patients: A first single-center experience.
|
Front Cardiovasc Med
36082124
|
1 |
3.6 |
2022 |
|
Sarcopenia and Frailty in Heart Failure: Is There a Biomarker Signature?
|
Curr Heart Fail Rep
36261756
|
3 |
3.288 |
2022 |
|
Pharmacological treatment options for heart failure with reduced ejection fraction: A 2022 update.
|
Expert Opin Pharmacother
35260016
|
0 |
3.2 |
2022 |
|
The fatter, the better in old age: the current understanding of a difficult relationship.
|
Curr Opin Clin Nutr Metab Care
34861670
|
2 |
3.1 |
2022 |
|
Glucose-Induced Hemodynamic and Metabolic Response of Skeletal Muscle in Heart Failure Patients with Reduced vs. Preserved Ejection Fraction-A Pilot Study.
|
J Cardiovasc Dev Dis
36547453
|
0 |
2.4 |
2022 |
|
Cardiac Cachexia Revisited: The Role of Wasting in Heart Failure.
|
Cardiol Clin
35465894
|
1 |
2.4 |
2022 |
|
[Management of chronic heart failure: state of the art according to the 2021 guideline].
|
Inn Med (Heidelb)
36125514
|
0 |
0.01 |
2022 |
|
Atrial disease and heart failure: the common soil hypothesis proposed by the Heart Failure Association of the European Society of Cardiology.
|
Eur Heart J
34875053
|
5 |
35.855 |
2021 |
|
The effect of intravenous ferric carboxymaltose on health-related quality of life in iron-deficient patients with acute heart failure: the results of the AFFIRM-AHF study.
|
Eur Heart J
34080008
|
28 |
35.855 |
2021 |
|
Ventricular tachycardia, premature ventricular contractions, and mortality in unselected patients with lung, colon, or pancreatic cancer: a prospective study.
|
Eur J Heart Fail
33222388
|
9 |
17.349 |
2021 |
|
Prognostic impact of muscle and fat mass in patients with heart failure.
|
J Cachexia Sarcopenia Muscle
33939328
|
16 |
12.063 |
2021 |
|
Effects of statins on mitochondrial pathways.
|
J Cachexia Sarcopenia Muscle
33511728
|
41 |
12.063 |
2021 |
|
JCSM: growing together with cachexia and sarcopenia research.
|
J Cachexia Sarcopenia Muscle
34969163
|
2 |
12.063 |
2021 |
|
Ethical guidelines for publishing in the Journal of Cachexia, Sarcopenia and Muscle: update 2021.
|
J Cachexia Sarcopenia Muscle
34904399
|
152 |
12.063 |
2021 |
|
Long-term safety and efficacy of sodium zirconium cyclosilicate for hyperkalaemia in patients with mild/moderate versus severe/end-stage chronic kidney disease: comparative results from an open-label, Phase 3 study.
|
Nephrol Dial Transplant
32030422
|
13 |
7.186 |
2021 |
|
Spontaneous Non-Sustained Ventricular Tachycardia and Premature Ventricular Contractions and Their Prognostic Relevance in Patients with Cancer in Routine Care.
|
Cancers (Basel)
34065780
|
4 |
6.575 |
2021 |
|
Critical appraisal of the 2020 ESC guideline recommendations on diagnosis and risk assessment in patients with suspected non-ST-segment elevation acute coronary syndrome.
|
Clin Res Cardiol
33635437
|
4 |
6.138 |
2021 |
|
Sarcopenia and cachexia in chronic diseases: from mechanisms to treatment.
|
Pol Arch Intern Med
34775741
|
1 |
5.218 |
2021 |
|
An overview of anamorelin as a treatment option for cancer-associated anorexia and cachexia.
|
Expert Opin Pharmacother
33491505
|
5 |
4.103 |
2021 |
|
Adjuvant breast cancer treatments cardiotoxicity and modern methods of detection and prevention of cardiac complications.
|
ESC Heart Fail
33955207
|
11 |
3.612 |
2021 |
|
Iron deficiency in heart failure.
|
ESC Heart Fail
33932115
|
19 |
3.612 |
2021 |
|
Heart failure with preserved ejection fraction in coronavirus disease 2019 patients: the promising role of diuretic therapy in critically ill patients.
|
ESC Heart Fail
33442925
|
5 |
3.612 |
2021 |
|
A year in heart failure: an update of recent findings.
|
ESC Heart Fail
34918477
|
4 |
3.612 |
2021 |
|
Creating an impact, not an impression: ESC Heart Failure in its seventh year.
|
ESC Heart Fail
34622581
|
0 |
3.612 |
2021 |
|
Factors and Prognostic Significance of Impaired Exercise Tolerance in Women over 40 with Arterial Hypertension.
|
J Pers Med
34442403
|
1 |
3.508 |
2021 |
|
Safety and Efficacy of Intravenous Ferric Derisomaltose Compared to Iron Sucrose for Iron Deficiency Anemia in Patients with Chronic Kidney Disease With and Without Heart Failure.
|
Am J Cardiol
34162484
|
3 |
3.133 |
2021 |
|
Improving exercise capacity and quality of life using non-invasive heart failure treatments: evidence from clinical trials.
|
Eur J Heart Fail
32392403
|
29 |
17.349 |
2020 |
|
High soluble transferrin receptor in patients with heart failure: a measure of iron deficiency and a strong predictor of mortality.
|
Eur J Heart Fail
33111457
|
19 |
17.349 |
2020 |
|
A current and future outlook on upcoming technologies in remote monitoring of patients with heart failure.
|
Eur J Heart Fail
33111389
|
14 |
17.349 |
2020 |
|
Baseline cardiovascular risk assessment in cancer patients scheduled to receive cardiotoxic cancer therapies: a position statement and new risk assessment tools from the Cardio-Oncology Study Group of the Heart Failure Association of the European Society of Cardiology in collaboration with the International Cardio-Oncology Society.
|
Eur J Heart Fail
32463967
|
130 |
15.534 |
2020 |
|
Common mechanistic pathways in cancer and heart failure. A scientific roadmap on behalf of the Translational Research Committee of the Heart Failure Association (HFA) of the European Society of Cardiology (ESC).
|
Eur J Heart Fail
33094495
|
34 |
15.534 |
2020 |
|
Cachexia, muscle wasting, and frailty in cardiovascular disease.
|
Eur J Heart Fail
32949422
|
32 |
15.534 |
2020 |
|
Role of cardiovascular imaging in cancer patients receiving cardiotoxic therapies: a position statement on behalf of the Heart Failure Association (HFA), the European Association of Cardiovascular Imaging (EACVI) and the Cardio-Oncology Council of the European Society of Cardiology (ESC).
|
Eur J Heart Fail
32621569
|
84 |
15.534 |
2020 |
|
Role of serum biomarkers in cancer patients receiving cardiotoxic cancer therapies: a position statement from the Cardio-Oncology Study Group of the Heart Failure Association and the Cardio-Oncology Council of the European Society of Cardiology.
|
Eur J Heart Fail
33006257
|
71 |
15.534 |
2020 |
|
Pathophysiological mechanisms of statin-associated myopathies: possible role of the ubiquitin-proteasome system.
|
J Cachexia Sarcopenia Muscle
32743965
|
3 |
12.91 |
2020 |
|
Bone in heart failure.
|
J Cachexia Sarcopenia Muscle
32087616
|
7 |
12.91 |
2020 |
|
Muscle wasting as an independent predictor of survival in patients with chronic heart failure.
|
J Cachexia Sarcopenia Muscle
32767518
|
34 |
12.91 |
2020 |
|
The 10th year of the Journal of Cachexia, Sarcopenia and Muscle.
|
J Cachexia Sarcopenia Muscle
33340288
|
1 |
12.91 |
2020 |
|
Recent developments in the field of cachexia, sarcopenia, and muscle wasting: highlights from the 12th Cachexia Conference.
|
J Cachexia Sarcopenia Muscle
32049447
|
12 |
12.91 |
2020 |
|
Blocking myostatin: muscle mass equals muscle strength?
|
J Cachexia Sarcopenia Muscle
33340286
|
5 |
12.91 |
2020 |
|
MT-102 prevents tissue wasting and improves survival in a rat model of severe cancer cachexia.
|
J Cachexia Sarcopenia Muscle
32067370
|
8 |
12.91 |
2020 |
|
Nutrition in the spotlight in cachexia, sarcopenia and muscle: avoiding the wildfire.
|
J Cachexia Sarcopenia Muscle
33382196
|
18 |
12.063 |
2020 |
|
Weight loss, malnutrition, and cachexia in COVID-19: facts and numbers.
|
J Cachexia Sarcopenia Muscle
33382211
|
52 |
12.063 |
2020 |
|
Ferric carboxymaltose for iron deficiency at discharge after acute heart failure: a multicentre, double-blind, randomised, controlled trial.
|
Lancet
33197395
|
137 |
9.153 |
2020 |
|
Nutraceutical support in heart failure: a position paper of the International Lipid Expert Panel (ILEP).
|
Nutr Res Rev
32172721
|
12 |
7.8 |
2020 |
|
Selective androgen receptor modulators (SARMs) as pharmacological treatment for muscle wasting in ongoing clinical trials.
|
Expert Opin Investig Drugs
32476495
|
5 |
6.206 |
2020 |
|
Promising models for cancer-induced cachexia drug discovery.
|
Expert Opin Drug Discov
32050816
|
5 |
6.098 |
2020 |
|
Cancer Cachexia and Related Metabolic Dysfunction.
|
Int J Mol Sci
32230855
|
30 |
5.923 |
2020 |
|
Cardiotoxicity and Cardiovascular Biomarkers in Patients With Breast Cancer: Data From the GeparOcto-GBG 84 Trial.
|
J Am Heart Assoc
33191846
|
10 |
5.501 |
2020 |
|
Onco-Cardiology: Consensus Paper of the German Cardiac Society, the German Society for Pediatric Cardiology and Congenital Heart Defects and the German Society for Hematology and Medical Oncology.
|
Clin Res Cardiol
32405737
|
24 |
5.46 |
2020 |
|
Decreased Appendicular Skeletal Muscle Mass is Associated with Poor Outcomes after ST-Segment Elevation Myocardial Infarction.
|
J Atheroscler Thromb
32132340
|
9 |
4.928 |
2020 |
|
Inferior vena cava ultrasound in acute decompensated heart failure: design rationale of the CAVA-ADHF-DZHK10 trial.
|
ESC Heart Fail
31991063
|
2 |
4.411 |
2020 |
|
Muscle mass, muscle strength, and functional capacity in patients with heart failure of Chagas disease and other aetiologies.
|
ESC Heart Fail
32860353
|
2 |
4.411 |
2020 |
|
Heart failure in the last year: progress and perspective.
|
ESC Heart Fail
33277825
|
22 |
4.411 |
2020 |
|
Early rehabilitation after stroke: relationship between the heart rate variability and functional outcome.
|
ESC Heart Fail
33121218
|
3 |
4.411 |
2020 |
|
Ferric carboxymaltose for the treatment of iron-deficient heart failure patients: a systematic review and meta-analysis.
|
ESC Heart Fail
33586856
|
7 |
4.411 |
2020 |
|
ESC Heart Failure increases its impact factor.
|
ESC Heart Fail
33118326
|
1 |
4.411 |
2020 |
|
Heart failure and sleep-disordered breathing: susceptibility to reduced muscle strength and preclinical congestion (SICA-HF cohort).
|
ESC Heart Fail
32578399
|
5 |
4.411 |
2020 |
|
Hypokalaemia and outcomes in older patients hospitalized for heart failure.
|
ESC Heart Fail
32319205
|
4 |
4.411 |
2020 |
|
Acute effects of oral triglyceride load on dynamic changes in peripheral endothelial function in heart failure patients with reduced ejection fraction and healthy controls.
|
Nutr Metab Cardiovasc Dis
32682746
|
1 |
4.222 |
2020 |
|
Inflammatory biomarkers of frailty.
|
Exp Gerontol
32007546
|
29 |
4.032 |
2020 |
|
Correction to: Association of statin use and clinical outcomes in heart failure patients: a systematic review and meta-analysis.
|
Lipids Health Dis
32951597
|
0 |
3.876 |
2020 |
|
Cardiac Cachexia Revisited: The Role of Wasting in Heart Failure.
|
Heart Fail Clin
31735316
|
15 |
3.179 |
2020 |
|
[Cardiovascular fitness in oncology : Exercise and sport].
|
Internist (Berl)
33025125
|
0 |
0.743 |
2020 |
|
[Tumor effects on the heart and circulation].
|
Internist (Berl)
33052455
|
0 |
0.743 |
2020 |
|
[Cardio-oncology: At the crossroads between two fields].
|
Internist (Berl)
33025121
|
0 |
0.743 |
2020 |
|
Mortality and morbidity 1 year after stopping a remote patient management intervention: extended follow-up results from the telemedical interventional management in patients with heart failure II (TIM-HF2) randomised trial.
|
Lancet Digit Health
33328035
|
9 |
24.519 |
2019 |
|
The evolving obesity paradigm story: from heart failure to atrial fibrillation.
|
Eur Heart J
31009055
|
0 |
22.673 |
2019 |
|
Improve Management of acute heart failure with ProcAlCiTonin in EUrope: results of the randomized clinical trial IMPACT EU Biomarkers in Cardiology (BIC) 18.
|
Eur J Heart Fail
31833168
|
5 |
15.534 |
2019 |
|
Biomarker guidance allows a more personalized allocation of patients for remote patient management in heart failure: results from the TIM-HF2 trial.
|
Eur J Heart Fail
31129929
|
8 |
11.627 |
2019 |
|
Mid-regional pro-atrial natriuretic peptide for the early detection of non-acute heart failure.
|
Eur J Heart Fail
31209992
|
6 |
11.627 |
2019 |
|
ESC Heart Failure receives its first impact factor.
|
Eur J Heart Fail
31883221
|
0 |
11.627 |
2019 |
|
Intravenous iron supplementation is state of the art therapy in patients with heart failure and iron deficiency.
|
Eur J Heart Fail
31116486
|
1 |
11.627 |
2019 |
|
The Journal of Cachexia, Sarcopenia and Muscle in 2019.
|
J Cachexia Sarcopenia Muscle
31454183
|
1 |
9.802 |
2019 |
|
Recent developments in the field of cachexia, sarcopenia, and muscle wasting: highlights from the 11th Cachexia Conference.
|
J Cachexia Sarcopenia Muscle
30920774
|
13 |
9.802 |
2019 |
|
Orphan disease status of cancer cachexia in the USA and in the European Union: a systematic review.
|
J Cachexia Sarcopenia Muscle
30920776
|
58 |
9.802 |
2019 |
|
Body weight changes and incidence of cachexia after stroke.
|
J Cachexia Sarcopenia Muscle
30680953
|
16 |
9.802 |
2019 |
|
Ethical guidelines for publishing in the Journal of Cachexia, Sarcopenia and Muscle: update 2019.
|
J Cachexia Sarcopenia Muscle
31661195
|
305 |
9.802 |
2019 |
|
The Journal of Cachexia, Sarcopenia and Muscle stays the front-runner in geriatrics and gerontology.
|
J Cachexia Sarcopenia Muscle
31821753
|
1 |
9.802 |
2019 |
|
Sarcopenia: A Time for Action. An SCWD Position Paper.
|
J Cachexia Sarcopenia Muscle
31523937
|
162 |
9.802 |
2019 |
|
Sodium Zirconium Cyclosilicate among Individuals with Hyperkalemia: A 12-Month Phase 3 Study.
|
Clin J Am Soc Nephrol
31110051
|
41 |
6.628 |
2019 |
|
Micronutrient Depletion in Heart Failure: Common, Clinically Relevant and Treatable.
|
Int J Mol Sci
31717934
|
13 |
4.556 |
2019 |
|
Open access efforts begin to bloom: ESC Heart Failure gets full attention and first impact factor.
|
ESC Heart Fail
31657535
|
0 |
3.902 |
2019 |
|
Recent advances in cardio-oncology: a report from the 'Heart Failure Association 2019 and World Congress on Acute Heart Failure 2019'.
|
ESC Heart Fail
31884717
|
15 |
3.902 |
2019 |
|
Morbidity and mortality in patients with cardiovascular risk factors and obstructive sleep apnoea: results from the DIAST-CHF cohort.
|
Respir Med
31252205
|
8 |
3.095 |
2019 |
|
Association of statin use and clinical outcomes in heart failure patients: a systematic review and meta-analysis.
|
Lipids Health Dis
31672151
|
12 |
2.906 |
2019 |
|
Arterial Stiffness and Indices of Left Ventricular Diastolic Dysfunction in Patients with Embolic Stroke of Undetermined Etiology.
|
Dis Markers
31612072
|
2 |
2.738 |
2019 |
|
Novel biomarkers in heart failure and cardio-oncology.
|
Kardiol Pol
30912110
|
1 |
1.874 |
2019 |
|
Sarcopaenia complicating heart failure.
|
Eur Heart J Suppl
31885508
|
1 |
1.655 |
2019 |
|
Nutrient pattern analysis in critically ill patients using Omics technology (NAChO) - Study protocol for a prospective observational study.
|
Medicine (Baltimore)
30608424
|
0 |
1.552 |
2019 |
|
Sympatho-Vagal Imbalance is Associated with Sarcopenia in Male Patients with Heart Failure.
|
Arq Bras Cardiol
30970141
|
8 |
1.45 |
2019 |
|
[Biomarkers in acute medicine].
|
Internist (Berl)
31139871
|
0 |
0.47 |
2019 |
|
[The relevance of biomarkers in acute heart failure].
|
Internist (Berl)
31089771
|
0 |
0.47 |
2019 |
|
Why is Iron Deficiency Recognised as an Important Comorbidity in Heart Failure?
|
Card Fail Rev
31768275
|
4 |
0 |
2019 |
|
The Role of Nutraceuticals in Statin Intolerant Patients.
|
J Am Coll Cardiol
29957236
|
69 |
18.639 |
2018 |
|
Cancer and heart failure-more than meets the eye: common risk factors and co-morbidities.
|
Eur J Heart Fail
29943887
|
18 |
13.965 |
2018 |
|
Cancer diagnosis in patients with heart failure: epidemiology, clinical implications and gaps in knowledge.
|
Eur J Heart Fail
29464808
|
49 |
13.965 |
2018 |
|
Comparison of sarcopenia and cachexia in men with chronic heart failure: results from the Studies Investigating Co-morbidities Aggravating Heart Failure (SICA-HF).
|
Eur J Heart Fail
30160804
|
63 |
13.965 |
2018 |
|
The new Heart Failure Association journal - ESC Heart Failure.
|
Eur J Heart Fail
30561163
|
0 |
13.965 |
2018 |
|
Assessment of baroreflex sensitivity has no prognostic value in contemporary, optimally managed patients with mild-to-moderate heart failure with reduced ejection fraction: a retrospective analysis of 5-year survival.
|
Eur J Heart Fail
30191647
|
1 |
11.627 |
2018 |
|
Prosarcopenic Effects of Statins May Limit Their Effectiveness in Patients with Heart Failure.
|
Trends Pharmacol Sci
29502887
|
14 |
11.523 |
2018 |
|
Time to jump on the bandwagon: the Journal of Cachexia, Sarcopenia and Muscle in 2018.
|
J Cachexia Sarcopenia Muscle
30311438
|
4 |
10.754 |
2018 |
|
From meta-analysis to Cochrane reviews.
|
J Cachexia Sarcopenia Muscle
29873945
|
1 |
10.754 |
2018 |
|
Silver linings on the horizon: highlights from the 10th Cachexia Conference.
|
J Cachexia Sarcopenia Muscle
29417752
|
5 |
10.754 |
2018 |
|
Iron deficiency as energetic insult to skeletal muscle in chronic diseases.
|
J Cachexia Sarcopenia Muscle
30178922
|
24 |
10.754 |
2018 |
|
More variety with the Journal of Cachexia, Sarcopenia and Muscle: JCSM Clinical Reports and JCSM Rapid Communications have both gone live.
|
J Cachexia Sarcopenia Muscle
29608044
|
2 |
10.754 |
2018 |
|
Once I get on a puzzle, I can't get off: Cachexia and wasting in 2018.
|
J Cachexia Sarcopenia Muscle
30450844
|
1 |
10.754 |
2018 |
|
Iron Deficiency in Heart Failure: An Overview.
|
JACC Heart Fail
30553903
|
86 |
9.14 |
2018 |
|
Iron deficiency in patients with heart failure with preserved ejection fraction and its association with reduced exercise capacity, muscle strength and quality of life.
|
Clin Res Cardiol
30051186
|
31 |
5.268 |
2018 |
|
Subclinical hypothyroidism and the development of heart failure: an overview of risk and effects on cardiac function.
|
Clin Res Cardiol
30091084
|
11 |
5.268 |
2018 |
|
Identification and regulation of the long non-coding RNA Heat2 in heart failure.
|
J Mol Cell Cardiol
30445017
|
14 |
4.133 |
2018 |
|
Novel drugs for heart rate control in heart failure.
|
Heart Fail Rev
29594814
|
4 |
4.015 |
2018 |
|
Cardiac expression of neutrophil gelatinase-associated lipocalin in a model of cancer cachexia-induced cardiomyopathy.
|
ESC Heart Fail
30367561
|
7 |
3.902 |
2018 |
|
Prognostic performance of serial in-hospital measurements of copeptin and multiple novel biomarkers among patients with worsening heart failure: results from the MOLITOR study.
|
ESC Heart Fail
29476612
|
11 |
3.407 |
2018 |
|
Muscle wasting and sarcopenia in heart failure: a brief overview of the current literature.
|
ESC Heart Fail
30570227
|
18 |
3.407 |
2018 |
|
Modern-day cardio-oncology: a report from the 'Heart Failure and World Congress on Acute Heart Failure 2018'.
|
ESC Heart Fail
30570223
|
11 |
3.407 |
2018 |
|
Early identification of acute heart failure at the time of presentation: do natriuretic peptides make the difference?
|
ESC Heart Fail
29667356
|
3 |
3.407 |
2018 |
|
Decompensated Heart Failure and Renal Failure: What Is the Current Evidence?
|
Curr Heart Fail Rep
29987499
|
9 |
2.833 |
2018 |
|
Biomarkers, myocardial fibrosis and co-morbidities in heart failure with preserved ejection fraction: an overview.
|
Arch Med Sci
30002709
|
21 |
2.38 |
2018 |
|
The β-blocker uptitration in elderly with heart failure regarding biomarker levels: CIBIS-ELD substudy.
|
Biomark Med
30450925
|
1 |
2.268 |
2018 |
|
Therapeutic considerations of sarcopenia in heart failure patients.
|
Expert Rev Cardiovasc Ther
29308681
|
4 |
1.678 |
2018 |
|
Serum chloride levels in critical illness-the hidden story.
|
Intensive Care Med Exp
29654387
|
29 |
1.667 |
2018 |
|
Iron deficiency in heart failure.
|
J Cardiovasc Med (Hagerstown)
30222663
|
2 |
1.427 |
2018 |
|
Landiolol for rate control management of atrial fibrillation in patients with cardiac dysfunction.
|
Eur Heart J Suppl
30188957
|
6 |
1.321 |
2018 |
|
[Cachexia and sarcopenia in chronic heart failure : Change in muscle strength and muscle structure].
|
Internist (Berl)
29637239
|
1 |
0.427 |
2018 |
|
[Comorbidities in heart failure : An interdisciplinary challenge].
|
Internist (Berl)
29654519
|
0 |
0.427 |
2018 |
|
Bariatric Surgery or Intensive Medical Therapy for Diabetes after 5 Years.
|
N Engl J Med
28517922
|
1 |
79.258 |
2017 |
|
Role of microRNAs in wasting in heart failure.
|
Nat Rev Cardiol
28770867
|
4 |
15.162 |
2017 |
|
Muscle wasting and cachexia in heart failure: mechanisms and therapies.
|
Nat Rev Cardiol
28436486
|
97 |
15.162 |
2017 |
|
Ethical guidelines for publishing in the journal of cachexia, sarcopenia and muscle: update 2017.
|
J Cachexia Sarcopenia Muscle
29098794
|
245 |
12.511 |
2017 |
|
Acylated ghrelin treatment normalizes skeletal muscle mitochondrial oxidative capacity and AKT phosphorylation in rat chronic heart failure.
|
J Cachexia Sarcopenia Muscle
29098797
|
25 |
12.511 |
2017 |
|
Oodles of opportunities: the Journal of Cachexia, Sarcopenia and Muscle in 2017.
|
J Cachexia Sarcopenia Muscle
29076661
|
6 |
12.511 |
2017 |
|
Casting the net broader to confirm our imaginations: the long road to treating wasting disorders.
|
J Cachexia Sarcopenia Muscle
29168628
|
13 |
12.511 |
2017 |
|
Highlights from the 9th Cachexia Conference.
|
J Cachexia Sarcopenia Muscle
28631415
|
7 |
12.511 |
2017 |
|
Co-morbidities in heart failure beginning to sprout-and no end in sight?
|
Eur J Heart Fail
29271591
|
12 |
10.683 |
2017 |
|
Prevalence and clinical impact of iron deficiency and anaemia among outpatients with chronic heart failure: The PrEP Registry.
|
Clin Res Cardiol
28229219
|
36 |
4.455 |
2017 |
|
Sleep-Disordered Breathing in Acute Ischemic Stroke: A Mechanistic Link to Peripheral Endothelial Dysfunction.
|
J Am Heart Assoc
28893762
|
4 |
4.45 |
2017 |
|
Models of sarcopenia: Short review.
|
Int J Cardiol
28465116
|
19 |
4.034 |
2017 |
|
Animal models of cachexia and sarcopenia in chronic illness: Cardiac function, body composition changes and therapeutic results.
|
Int J Cardiol
28476513
|
17 |
4.034 |
2017 |
|
Updates in heart failure: Highlights from the Iranian Joint Cardiovascular Congress Tehran, Iran, 1-4 March 2016.
|
Int J Cardiol
28284507
|
1 |
4.034 |
2017 |
|
Sarcopenia, cachexia, and muscle performance in heart failure: Review update 2016.
|
Int J Cardiol
28427849
|
25 |
4.034 |
2017 |
|
Wasting away: How to treat cachexia and muscle wasting in chronic disease?
|
Br J Clin Pharmacol
28755533
|
2 |
3.838 |
2017 |
|
Androgen status in non-diabetic elderly men with heart failure.
|
Aging Male
28696825
|
2 |
2.5 |
2017 |
|
Biomarkers for physical frailty and sarcopenia.
|
Aging Clin Exp Res
28155180
|
20 |
2.121 |
2017 |
|
[Iron Deficiency in Chronic Heart Failure: Diagnostic Algorithm and Present-Day Therapeutic Options].
|
Dtsch Med Wochenschr
28303555
|
3 |
0.523 |
2017 |
|
[Indications and Clinical Implications of the Use of the Cardiac Markers BNP and NT-proBNP].
|
Dtsch Med Wochenschr
28282683
|
1 |
0.523 |
2017 |
|
[Iron deficiency : Recognition and treatment].
|
Internist (Berl)
28540476
|
0 |
0.44 |
2017 |
|
Anorexia, functional capacity, and clinical outcome in patients with chronic heart failure: results from the Studies Investigating Co-morbidities Aggravating Heart Failure (SICA-HF).
|
ESC Heart Fail
28960880
|
38 |
0 |
2017 |
|
Relationship between skeletal muscle mass and cardiac function during exercise in community-dwelling older adults.
|
ESC Heart Fail
29154420
|
11 |
0 |
2017 |
|
Sleep-disordered breathing in heart failure: facts and numbers.
|
ESC Heart Fail
28772039
|
8 |
0 |
2017 |
|
Publishing in a heart failure journal-where lies the scientific interest?
|
ESC Heart Fail
29131547
|
1 |
0 |
2017 |
|
Weight Loss and Health Status after Bariatric Surgery in Adolescents.
|
N Engl J Med
27192679
|
2 |
72.406 |
2016 |
|
Intestinal congestion and right ventricular dysfunction: a link with appetite loss, inflammation, and cachexia in chronic heart failure.
|
Eur Heart J
26865478
|
59 |
20.212 |
2016 |
|
Diabetes and Heart Failure: Sugared Words Prove Bitter.
|
J Am Coll Cardiol
27659463
|
1 |
19.896 |
2016 |
|
Heart failure and kidney dysfunction: epidemiology, mechanisms and management.
|
Nat Rev Nephrol
27573728
|
183 |
12.146 |
2016 |
|
Megestrol acetate improves cardiac function in a model of cancer cachexia-induced cardiomyopathy by autophagic modulation.
|
J Cachexia Sarcopenia Muscle
27239419
|
29 |
9.697 |
2016 |
|
Espindolol for the treatment and prevention of cachexia in patients with stage III/IV non-small cell lung cancer or colorectal cancer: a randomized, double-blind, placebo-controlled, international multicentre phase II study (the ACT-ONE trial).
|
J Cachexia Sarcopenia Muscle
27386169
|
58 |
9.697 |
2016 |
|
Prevalence and clinical impact of cachexia in chronic illness in Europe, USA, and Japan: facts and numbers update 2016.
|
J Cachexia Sarcopenia Muscle
27891294
|
98 |
9.697 |
2016 |
|
Nutrition in cachexia: from bench to bedside.
|
J Cachexia Sarcopenia Muscle
27030816
|
17 |
9.697 |
2016 |
|
Welcome to the ICD-10 code for sarcopenia.
|
J Cachexia Sarcopenia Muscle
27891296
|
242 |
9.697 |
2016 |
|
Dysfunction of respiratory muscles in critically ill patients on the intensive care unit.
|
J Cachexia Sarcopenia Muscle
27030815
|
43 |
9.697 |
2016 |
|
Moving upwards - the journal of cachexia, sarcopenia and muscle in 2016.
|
J Cachexia Sarcopenia Muscle
27625918
|
3 |
9.697 |
2016 |
|
Cachexia research in Japan: facts and numbers on prevalence, incidence and clinical impact.
|
J Cachexia Sarcopenia Muscle
27239422
|
12 |
9.697 |
2016 |
|
The times they are a-changin': the Cachexia Conference goes annual.
|
J Cachexia Sarcopenia Muscle
27066313
|
4 |
9.697 |
2016 |
|
Unlocking the wasting enigma: Highlights from the 8th Cachexia Conference.
|
J Cachexia Sarcopenia Muscle
27128291
|
23 |
9.697 |
2016 |
|
Concerning the Role of Gender Difference in Obesity Paradox in Patients With Heart Failure.
|
JACC Heart Fail
26940631
|
1 |
8.493 |
2016 |
|
Effects of intravenous iron therapy in iron-deficient patients with systolic heart failure: a meta-analysis of randomized controlled trials.
|
Eur J Heart Fail
26821594
|
96 |
6.968 |
2016 |
|
Resting heart rate is an independent predictor of death in patients with colorectal, pancreatic, and non-small cell lung cancer: results of a prospective cardiovascular long-term study.
|
Eur J Heart Fail
27910284
|
39 |
6.968 |
2016 |
|
ESC Heart Failure: a new journal aims to broaden heart failure views.
|
Eur J Heart Fail
27910285
|
0 |
6.968 |
2016 |
|
Iron deficiency and risk of early readmission following a hospitalization for acute heart failure.
|
Eur J Heart Fail
27292134
|
0 |
6.968 |
2016 |
|
Adding insult to injury: heart failure and incident cancer.
|
Eur J Heart Fail
26833681
|
2 |
6.968 |
2016 |
|
Erythropoietin improves cardiac wasting and outcomes in a rat model of liver cancer cachexia.
|
Int J Cardiol
27240157
|
4 |
6.189 |
2016 |
|
Differences in biochemical and genetic biomarkers in patients with heart failure of various etiologies.
|
Int J Cardiol
27448535
|
16 |
6.189 |
2016 |
|
The influence of confounders in the analysis of mid-regional pro-atrial natriuretic peptide in patients with chronic heart failure.
|
Int J Cardiol
27288971
|
1 |
6.189 |
2016 |
|
Neuromuscular electrical stimulation for muscle wasting in heart failure patients.
|
Int J Cardiol
27728864
|
4 |
6.189 |
2016 |
|
Sarcopenia in patients with heart failure with preserved ejection fraction: Impact on muscle strength, exercise capacity and quality of life.
|
Int J Cardiol
27454614
|
80 |
6.189 |
2016 |
|
Sarcopenia and Endothelial Function in Patients With Chronic Heart Failure: Results From the Studies Investigating Comorbidities Aggravating Heart Failure (SICA-HF).
|
J Am Med Dir Assoc
27816483
|
26 |
5.325 |
2016 |
|
Influence of core body temperature on Tryptophan metabolism, kynurenines, and estimated IDO activity in critically ill patients receiving target temperature management following cardiac arrest.
|
Resuscitation
27565863
|
3 |
5.23 |
2016 |
|
Increased Activity of the Immunoregulatory Enzyme Indoleamine-2,3-Dioxygenase with Consecutive Tryptophan Depletion Predicts Death in Patients with Neuroendocrine Neoplasia.
|
Neuroendocrinology
26954941
|
1 |
5.024 |
2016 |
|
Longer-term impact of hemiparetic stroke on skeletal muscle metabolism-A pilot study.
|
Int J Cardiol
28063669
|
3 |
4.034 |
2016 |
|
Central Chemoreceptor Sensitivity Is Not Enhanced in Contemporary Patients With Chronic Systolic Heart Failure Receiving Optimal Treatment.
|
J Card Fail
27867115
|
1 |
3.942 |
2016 |
|
Impact of Plasma Kynurenine Level on Functional Capacity and Outcome in Heart Failure - Results From Studies Investigating Co-morbidities Aggravating Heart Failure (SICA-HF).
|
Circ J
27904018
|
12 |
3.544 |
2016 |
|
Testosterone Deficiency and Testosterone Treatment in Older Men.
|
Gerontology
27855417
|
36 |
3.532 |
2016 |
|
The need for re-defining cut-off values in heart failure: From obesity to iron deficiency.
|
Exp Gerontol
27989924
|
1 |
3.224 |
2016 |
|
Secondary hyperparathyroidism prevalence and prognostic role in elderly males with heart failure.
|
J Endocrinol Invest
27738907
|
5 |
3.166 |
2016 |
|
ACE Inhibitors and Sarcopenia: Covering All the BASEs?
|
Drugs Aging
27830566
|
3 |
2.769 |
2016 |
|
Could gonadal and adrenal androgen deficiencies contribute to the depressive symptoms in men with systolic heart failure?
|
Aging Male
27650467
|
3 |
2.108 |
2016 |
|
Influence of essential amino acids on muscle mass and muscle strength in patients with cerebral stroke during early rehabilitation: protocol and rationale of a randomized clinical trial (AMINO-Stroke Study).
|
BMC Neurol
26793971
|
4 |
2.006 |
2016 |
|
Muscle wasting in heart failure : The role of nutrition.
|
Wien Klin Wochenschr
27761739
|
11 |
0.974 |
2016 |
|
Nutritional status and its effects on muscle wasting in patients with chronic heart failure: insights from Studies Investigating Co-morbidities Aggravating Heart Failure.
|
Wien Klin Wochenschr
27853883
|
18 |
0.974 |
2016 |
|
Iron and Exercise in Heart Failure: How to Assess Relevant Changes?
|
Rev Esp Cardiol (Engl Ed)
26839057
|
0 |
0.146 |
2016 |
|
Estimating fat mass in heart failure patients.
|
Arch Med Sci Atheroscler Dis
28905026
|
1 |
0 |
2016 |
|
Heart failure epidemiology and novel treatments in Japan: facts and numbers.
|
ESC Heart Fail
27840692
|
38 |
0 |
2016 |
|
Protective overweight in cardiovascular disease: moving from 'paradox' to 'paradigm'.
|
Eur Heart J
26341892
|
14 |
20.212 |
2015 |
|
Reply: Cardiovascular function and exercise capacity in patients with colorectal cancer: does anticancer therapy matter?
|
J Am Coll Cardiol
25835455
|
0 |
19.896 |
2015 |
|
Iron deficiency and cardiovascular disease.
|
Nat Rev Cardiol
26194551
|
89 |
14.299 |
2015 |
|
More colour to the Journal: new style, new publisher, but still Cachexia, Sarcopenia and Muscle.
|
J Cachexia Sarcopenia Muscle
26136408
|
4 |
9.697 |
2015 |
|
Evaluation of C-terminal Agrin Fragment as a marker of muscle wasting in patients after acute stroke during early rehabilitation.
|
J Cachexia Sarcopenia Muscle
27066319
|
28 |
9.697 |
2015 |
|
Biomarkers for physical frailty and sarcopenia: state of the science and future developments.
|
J Cachexia Sarcopenia Muscle
26675566
|
86 |
9.697 |
2015 |
|
Higher serum phosphorus is associated with catabolic/anabolic imbalance in heart failure.
|
J Cachexia Sarcopenia Muscle
26672973
|
10 |
9.697 |
2015 |
|
Febuxostat improves outcome in a rat model of cancer cachexia.
|
J Cachexia Sarcopenia Muscle
26136193
|
8 |
9.697 |
2015 |
|
Moving on up: the Journal of Cachexia, Sarcopenia and Muscle.
|
J Cachexia Sarcopenia Muscle
26401464
|
2 |
9.697 |
2015 |
|
Request for regulatory guidance for cancer cachexia intervention trials.
|
J Cachexia Sarcopenia Muscle
26675232
|
56 |
9.697 |
2015 |
|
Ethical guidelines for publishing in the Journal of Cachexia, Sarcopenia and Muscle: update 2015.
|
J Cachexia Sarcopenia Muscle
26672494
|
173 |
9.697 |
2015 |
|
Insulin resistance in heart failure: differences between patients with reduced and preserved left ventricular ejection fraction.
|
Eur J Heart Fail
26198713
|
19 |
6.968 |
2015 |
|
Detection of muscle wasting in patients with chronic heart failure using C-terminal agrin fragment: results from the Studies Investigating Co-morbidities Aggravating Heart Failure (SICA-HF).
|
Eur J Heart Fail
26449626
|
22 |
6.968 |
2015 |
|
In reply: Treatment of cachexia: An overview of recent developments.
|
Int J Cardiol
26313859
|
0 |
6.189 |
2015 |
|
PURE muscle and more.
|
Int J Cardiol
26433767
|
2 |
6.189 |
2015 |
|
The impact of iron deficiency and anaemia on exercise capacity and outcomes in patients with chronic heart failure. Results from the Studies Investigating Co-morbidities Aggravating Heart Failure.
|
Int J Cardiol
26705670
|
34 |
6.189 |
2015 |
|
Treatment of Muscle Wasting: An Overview of Promising Treatment Targets.
|
J Am Med Dir Assoc
26593302
|
0 |
5.775 |
2015 |
|
Lipopolysaccharide responsiveness is an independent predictor of death in patients with chronic heart failure.
|
J Mol Cell Cardiol
26264758
|
6 |
5.68 |
2015 |
|
The CD4(+) AT2R(+) T cell subpopulation improves post-infarction remodelling and restores cardiac function.
|
J Cell Mol Med
25991381
|
23 |
4.499 |
2015 |
|
The wasting continuum in heart failure: from sarcopenia to cachexia.
|
Proc Nutr Soc
26264581
|
41 |
4.421 |
2015 |
|
Biomarkers and echocardiographic predictors of myocardial dysfunction in patients with hypertension.
|
Sci Rep
25747153
|
15 |
4.259 |
2015 |
|
Developing models for cachexia and their implications in drug discovery.
|
Expert Opin Drug Discov
25927848
|
8 |
3.876 |
2015 |
|
Interleukin-10 receptor-1 expression in monocyte-derived antigen-presenting cell populations: dendritic cells partially escape from IL-10's inhibitory mechanisms.
|
Genes Immun
26201975
|
0 |
2.524 |
2015 |
|
Should procalcitonin be measured routinely in acute decompensated heart failure?
|
Biomark Med
26174839
|
4 |
2.02 |
2015 |
|
Effects of dialysis modality on blood loss, bleeding complications and transfusion requirements in critically ill patients with dialysis-dependent acute renal failure.
|
Anaesth Intensive Care
26603802
|
5 |
1.695 |
2015 |
|
Iohexol clearance is superior to creatinine-based renal function estimating equations in detecting short-term renal function decline in chronic heart failure.
|
Croat Med J
26718759
|
2 |
1.619 |
2015 |
|
Diminished HLA-DR expression on monocyte and dendritic cell subsets indicating impairment of cellular immunity in pre-term neonates: a prospective observational analysis.
|
J Perinat Med
25418981
|
7 |
1.577 |
2015 |
|
Skeletal muscle weakness is related to insulin resistance in patients with chronic heart failure.
|
ESC Heart Fail
28834658
|
17 |
0 |
2015 |
|
Sleep-disordered breathing and cardiovascular disease.
|
Indian Heart J
27056657
|
6 |
0 |
2015 |
|
Single baseline serum creatinine measurements predict mortality in critically ill patients hospitalized for acute heart failure.
|
ESC Heart Fail
27774258
|
6 |
0 |
2015 |
|
The appropriate dose of angiotensin-converting-enzyme inhibitors or angiotensin receptor blockers in patients with dilated cardiomyopathy. The higher, the better?
|
ESC Heart Fail
27774257
|
4 |
0 |
2015 |
|
Abnormal serum calcium levels are associated with clinical response to maximization of heart failure therapy.
|
Pol Arch Med Wewn
25578437
|
2 |
0 |
2015 |
|
ICU-acquired weakness and recovery from critical illness.
|
N Engl J Med
25014705
|
0 |
72.406 |
2014 |
|
Intestinal blood flow in patients with chronic heart failure: a link with bacterial growth, gastrointestinal symptoms, and cachexia.
|
J Am Coll Cardiol
25212642
|
80 |
19.896 |
2014 |
|
Cardiovascular function and predictors of exercise capacity in patients with colorectal cancer.
|
J Am Coll Cardiol
25257631
|
44 |
19.896 |
2014 |
|
Efforts begin to sprout: publications in JCSM on cachexia, sarcopenia and muscle wasting receive attention.
|
J Cachexia Sarcopenia Muscle
25192875
|
10 |
9.697 |
2014 |
|
Are we closer to having drugs to treat muscle wasting disease?
|
J Cachexia Sarcopenia Muscle
24865381
|
36 |
9.697 |
2014 |
|
Muscle wasting disease: a proposal for a new disease classification.
|
J Cachexia Sarcopenia Muscle
24595459
|
48 |
9.697 |
2014 |
|
Highlights from the 7th Cachexia Conference: muscle wasting pathophysiological detection and novel treatment strategies.
|
J Cachexia Sarcopenia Muscle
24595460
|
32 |
9.697 |
2014 |
|
Prevalence, incidence, and clinical impact of sarcopenia: facts, numbers, and epidemiology-update 2014.
|
J Cachexia Sarcopenia Muscle
25425503
|
198 |
9.697 |
2014 |
|
Prevalence, incidence and clinical impact of cachexia: facts and numbers-update 2014.
|
J Cachexia Sarcopenia Muscle
25384990
|
153 |
9.697 |
2014 |
|
From sarcopenia to frailty: a road less traveled.
|
J Cachexia Sarcopenia Muscle
24526568
|
44 |
9.697 |
2014 |
|
Muscle wasting: an overview of recent developments in basic research.
|
J Cachexia Sarcopenia Muscle
25163459
|
22 |
9.697 |
2014 |
|
Serum phosphorus level is related to degree of clinical response to up-titration of heart failure pharmacotherapy.
|
Int J Cardiol
25499388
|
2 |
6.189 |
2014 |
|
Treatment of cachexia: An overview of recent developments.
|
Int J Cardiol
25804188
|
24 |
6.189 |
2014 |
|
Bone marrow iron depletion is common in patients with coronary artery disease.
|
Int J Cardiol
25661858
|
12 |
6.189 |
2014 |
|
Mid-regional proadrenomedullin levels predict recurrence of atrial fibrillation after catheter ablation.
|
Int J Cardiol
25438233
|
4 |
6.189 |
2014 |
|
Muscle wasting: an overview of recent developments in basic research.
|
Int J Cardiol
25205489
|
11 |
6.189 |
2014 |
|
Catabolic signaling and muscle wasting after acute ischemic stroke in mice: indication for a stroke-specific sarcopenia.
|
Stroke
25352483
|
37 |
6.032 |
2014 |
|
Treatment of cachexia: an overview of recent developments.
|
J Am Med Dir Assoc
25455531
|
32 |
5.775 |
2014 |
|
The effect of continuous versus intermittent renal replacement therapy on the outcome of critically ill patients with acute renal failure (CONVINT): a prospective randomized controlled trial.
|
Crit Care
24405734
|
50 |
5.358 |
2014 |
|
An overview of recent developments in the treatment of heart failure: update from the ESC Congress 2013.
|
Expert Opin Investig Drugs
24490905
|
7 |
4.03 |
2014 |
|
Matrix metalloproteinase 9/neutrophil gelatinase associated lipocalin/tissue inhibitor of metalloproteinasess type 1 complexes are localized within cardiomyocytes and serve as a reservoir of active metalloproteinase in porcine female myocardium.
|
J Physiol Pharmacol
24930508
|
3 |
2.883 |
2014 |
|
Interleukin-10 receptor-1 expression in monocyte-derived antigen-presenting cell populations: dendritic cells partially escape from IL-10's inhibitory mechanisms.
|
Genes Immun
25472783
|
7 |
2.524 |
2014 |
|
Molecular mechanisms and treatment targets of muscle wasting and cachexia in heart failure: an overview.
|
Curr Opin Support Palliat Care
24452279
|
14 |
2.045 |
2014 |
|
[Iron deficiency in chronic heart failure: from diagnosis to therapy].
|
Dtsch Med Wochenschr
24722935
|
1 |
0.552 |
2014 |
|
Research in acute and chronic heart failure is busier then ever worldwide and demands more publishing space: introducing ESC Heart Failure, the sister journal of the European Journal of Heart Failure.
|
ESC Heart Fail
28834670
|
1 |
0 |
2014 |
|
Late-onset hypogonadism in men with systolic heart failure: prevalence, clinical associates, and impact on long-term survival.
|
ESC Heart Fail
28834667
|
2 |
0 |
2014 |
|
Prevention of liver cancer cachexia-induced cardiac wasting and heart failure.
|
Eur Heart J
23990596
|
84 |
20.212 |
2013 |
|
Cardiac hepatopathy versus end-stage liver disease: two different entities.
|
J Am Coll Cardiol
24315902
|
2 |
19.896 |
2013 |
|
Iron status and survival in diabetic patients with coronary artery disease.
|
Diabetes Care
24130349
|
26 |
11.857 |
2013 |
|
Investigation of changes in body composition, metabolic profile and skeletal muscle functional capacity in ischemic stroke patients: the rationale and design of the Body Size in Stroke Study (BoSSS).
|
J Cachexia Sarcopenia Muscle
23483531
|
13 |
9.697 |
2013 |
|
The anabolic catabolic transforming agent (ACTA) espindolol increases muscle mass and decreases fat mass in old rats.
|
J Cachexia Sarcopenia Muscle
24272787
|
25 |
9.697 |
2013 |
|
Cachexia vs obesity: where is the real unmet clinical need?
|
J Cachexia Sarcopenia Muscle
24197816
|
8 |
9.697 |
2013 |
|
Cachexia as a major public health problem: frequent, costly, and deadly.
|
J Cachexia Sarcopenia Muscle
23539127
|
65 |
9.697 |
2013 |
|
Increased catabolic activity in adipose tissue of patients with chronic heart failure.
|
Eur J Heart Fail
23696611
|
19 |
6.968 |
2013 |
|
Value of serum pregnancy-associated plasma protein A for predicting cardiovascular events among patients presenting with cardiac chest pain.
|
CMAJ
23509133
|
5 |
6.784 |
2013 |
|
Weight reduction in patients with coronary artery disease: comparison of Traditional Tibetan Medicine and Western diet.
|
Int J Cardiol
23890855
|
6 |
6.189 |
2013 |
|
Simvastatin reduces wasting and improves cardiac function as well as outcome in experimental cancer cachexia.
|
Int J Cardiol
23680591
|
17 |
6.189 |
2013 |
|
Frailty and heart disease.
|
Int J Cardiol
23931976
|
18 |
6.189 |
2013 |
|
Cardiac cachexia is associated with right ventricular failure and liver dysfunction.
|
Int J Cardiol
24063924
|
16 |
6.189 |
2013 |
|
TWIST1 regulates the activity of ubiquitin proteasome system via the miR-199/214 cluster in human end-stage dilated cardiomyopathy.
|
Int J Cardiol
23360823
|
23 |
6.189 |
2013 |
|
Heart failure biomarkers in patients with dilated cardiomyopathy.
|
Int J Cardiol
23416015
|
17 |
6.189 |
2013 |
|
The xanthine oxidase inhibitor oxypurinol reduces cancer cachexia-induced cardiomyopathy.
|
Int J Cardiol
23751350
|
12 |
6.189 |
2013 |
|
Stroke induced Sarcopenia: muscle wasting and disability after stroke.
|
Int J Cardiol
24231058
|
85 |
6.189 |
2013 |
|
Functional iron deficiency and diastolic function in heart failure with preserved ejection fraction.
|
Int J Cardiol
23968714
|
19 |
6.189 |
2013 |
|
Tandospirone reduces wasting and improves cardiac function in experimental cancer cachexia.
|
Int J Cardiol
24207070
|
8 |
6.189 |
2013 |
|
Effect of application route of the ghrelin analog BIM-28131 (RM-131) on body weight and body composition in a rat heart failure model.
|
Int J Cardiol
23465234
|
8 |
6.189 |
2013 |
|
Tele-accelerometry as a novel technique for assessing functional status in patients with heart failure: feasibility, reliability and patient safety.
|
Int J Cardiol
23962782
|
18 |
6.189 |
2013 |
|
Resting energy expenditure and the effects of muscle wasting in patients with chronic heart failure: results from the Studies Investigating Comorbidities Aggravating Heart Failure (SICA-HF).
|
J Am Med Dir Assoc
24094897
|
11 |
5.775 |
2013 |
|
Frailty consensus: a call to action.
|
J Am Med Dir Assoc
23764209
|
1036 |
5.775 |
2013 |
|
Pharmacokinetics of drugs in cachectic patients: a systematic review.
|
PLoS One
24282510
|
32 |
4.034 |
2013 |
|
Recent developments in the treatment of heart failure: highlights from the American Heart Association's Scientific Sessions, Los Angeles, California, 3 - 7 December 2012.
|
Expert Opin Investig Drugs
23656525
|
2 |
4.03 |
2013 |
|
Plasma adiponectin in heart failure with and without cachexia: catabolic signal linking catabolism, symptomatic status, and prognosis.
|
Nutr Metab Cardiovasc Dis
23791298
|
31 |
3.679 |
2013 |
|
Iron deficiency in heart failure: a practical guide.
|
Nutrients
24064572
|
13 |
3.55 |
2013 |
|
Muscle wasting in heart failure: An overview.
|
Int J Biochem Cell Biol
23665153
|
45 |
3.505 |
2013 |
|
Mechanism and novel therapeutic approaches to wasting in chronic disease.
|
Maturitas
23664695
|
21 |
3.255 |
2013 |
|
Rosiglitazone reduces body wasting and improves survival in a rat model of cancer cachexia.
|
Nutrition
24976415
|
5 |
3.099 |
2013 |
|
Association of adiponectin with peripheral muscle status in elderly patients with heart failure.
|
Eur J Intern Med
24095654
|
25 |
2.96 |
2013 |
|
The role of micronutrients and macronutrients in patients hospitalized for heart failure.
|
Heart Fail Clin
23809420
|
4 |
2.124 |
2013 |
|
The influence of atorvastatin on parameters of inflammation left ventricular function, hospitalizations and mortality in patients with dilated cardiomyopathy--5-year follow-up.
|
Lipids Health Dis
23566246
|
13 |
2.073 |
2013 |
|
Non-invasive assessment of cardiac hemodynamics in patients with advanced cancer and with chronic heart failure: a pilot feasibility study.
|
Arch Med Sci
23671436
|
5 |
1.969 |
2013 |
|
Highlights of mechanistic and therapeutic cachexia and sarcopenia research 2010 to 2012 and their relevance for cardiology.
|
Arch Med Sci
23515589
|
13 |
1.969 |
2013 |
|
Anabolic deficiencies in men with systolic heart failure: do co-morbidities and therapies really contribute significantly?
|
Aging Male
23803163
|
1 |
1.85 |
2013 |
|
Elevated PAPP-A sets alarm bells ringing in patients with cardiac chest pain.
|
Expert Rev Cardiovasc Ther
24325177
|
1 |
1.632 |
2013 |
|
Andropausal syndrome in men with systolic heart failure.
|
Pol Arch Med Wewn
23449158
|
3 |
0 |
2013 |
|
Vitamin D in chronic kidney disease: more questions than answers.
|
JAMA
22337683
|
5 |
44.405 |
2012 |
|
Does obesity make it better or worse: insights into cardiovascular illnesses.
|
Eur Heart J
22947611
|
4 |
20.212 |
2012 |
|
Muscle wasting in patients with chronic heart failure: results from the studies investigating co-morbidities aggravating heart failure (SICA-HF).
|
Eur Heart J
23178647
|
189 |
20.212 |
2012 |
|
Iron deficiency and heart failure: diagnostic dilemmas and therapeutic perspectives.
|
Eur Heart J
23100285
|
114 |
20.212 |
2012 |
|
Iron status in patients with chronic heart failure.
|
Eur Heart J
23178646
|
59 |
20.212 |
2012 |
|
Ursodeoxycholic acid in patients with chronic heart failure: a double-blind, randomized, placebo-controlled, crossover trial.
|
J Am Coll Cardiol
22300693
|
32 |
19.896 |
2012 |
|
Elevated plasma levels of neuropeptide proenkephalin a predict mortality and functional outcome in ischemic stroke.
|
J Am Coll Cardiol
22813614
|
17 |
19.896 |
2012 |
|
The muscle in dire straits: mechanisms of wasting in heart failure.
|
Circulation
22565939
|
1 |
19.309 |
2012 |
|
Recent developments in the treatment of cachexia: highlights from the 6th Cachexia Conference.
|
J Cachexia Sarcopenia Muscle
22460618
|
12 |
9.697 |
2012 |
|
The obesity paradox in chronic disease: facts and numbers.
|
J Cachexia Sarcopenia Muscle
22450395
|
49 |
9.697 |
2012 |
|
From muscle wasting to sarcopenia and myopenia: update 2012.
|
J Cachexia Sarcopenia Muscle
23160774
|
57 |
9.697 |
2012 |
|
Erratum to: Recent developments in the treatment of cachexia: highlights from the 6th Cachexia Conference.
|
J Cachexia Sarcopenia Muscle
22614821
|
0 |
9.697 |
2012 |
|
The relevance of congestion in the cardio-renal syndrome.
|
Kidney Int
23254894
|
38 |
8.395 |
2012 |
|
Inhibition of xanthine oxidase reduces wasting and improves outcome in a rat model of cancer cachexia.
|
Int J Cancer
22336965
|
26 |
6.513 |
2012 |
|
Muscle in heart disease: highlights from the European Society of Cardiology's Annual Meeting 2012.
|
Int J Cardiol
23121913
|
1 |
6.189 |
2012 |
|
Cachexia as major underestimated unmet medical need: facts and numbers.
|
Int J Cardiol
23084543
|
16 |
6.189 |
2012 |
|
Anaemia predicts health related quality of life in heart failure patients.
|
Int J Cardiol
23127613
|
1 |
6.189 |
2012 |
|
No train, no gain: does this apply to heart failure with preserved ejection fraction?
|
Int J Cardiol
23121915
|
1 |
6.189 |
2012 |
|
Improved insulin sensitivity by the angiotensin receptor antagonist irbesartan in patients with systolic heart failure: a randomized double-blinded placebo-controlled study.
|
Int J Cardiol
21856022
|
4 |
6.189 |
2012 |
|
Highlights of the mechanistic and therapeutic cachexia and sarcopenia research 2010 to 2012 and their relevance for cardiology.
|
Int J Cardiol
23174169
|
10 |
6.189 |
2012 |
|
Copeptin as a prognostic factor for major adverse cardiovascular events in patients with coronary artery disease.
|
Int J Cardiol
22284271
|
17 |
6.189 |
2012 |
|
Liver metabolism in cardiac cachexia.
|
Int J Cardiol
23122623
|
0 |
6.189 |
2012 |
|
Mid-regional pro-atrial natriuretic peptide as a prognostic marker for all-cause mortality in patients with symptomatic coronary artery disease.
|
Clin Sci (Lond)
22690794
|
2 |
4.936 |
2012 |
|
Assessment of serum cotinine in patients with chronic heart failure: self-reported versus objective smoking behaviour.
|
Clin Res Cardiol
22878732
|
3 |
4.76 |
2012 |
|
Role of iron deficiency and anemia in cardio-renal syndromes.
|
Semin Nephrol
22365163
|
5 |
3.598 |
2012 |
|
Anemia in chronic heart failure: can we treat? What to treat?
|
Heart Fail Rev
21979835
|
15 |
3.481 |
2012 |
|
Liver dysfunction and its nutritional implications in heart failure.
|
Nutrition
23022119
|
15 |
3.146 |
2012 |
|
Limitations of gait speed as an independent predictor of mortality and morbidity in cardiac patients.
|
J Am Coll Cardiol
21816319
|
0 |
19.896 |
2011 |
|
The 6th Cachexia Conference: an introduction to clinical and basic research in an exiting area.
|
J Cachexia Sarcopenia Muscle
22207906
|
2 |
9.697 |
2011 |
|
IGF-1 treatment reduces weight loss and improves outcome in a rat model of cancer cachexia.
|
J Cachexia Sarcopenia Muscle
21766056
|
25 |
9.697 |
2011 |
|
Growth hormone, insulin-like growth factor 1, and insulin signaling-a pharmacological target in body wasting and cachexia.
|
J Cachexia Sarcopenia Muscle
22207907
|
24 |
9.697 |
2011 |
|
The role of myostatin in muscle wasting: an overview.
|
J Cachexia Sarcopenia Muscle
21966641
|
141 |
9.697 |
2011 |
|
Ursodeoxycholic acid treatment in a rat model of cancer cachexia.
|
J Cachexia Sarcopenia Muscle
22450540
|
12 |
9.697 |
2011 |
|
Body mass index and prognosis in patients hospitalized with acute exacerbation of chronic obstructive pulmonary disease.
|
J Cachexia Sarcopenia Muscle
21766053
|
48 |
9.697 |
2011 |
|
Cachexia in heart disease: highlights from the ESC 2010.
|
J Cachexia Sarcopenia Muscle
21475672
|
12 |
9.697 |
2011 |
|
Copeptin--a novel marker in acute myocardial infarction.
|
Clin Chem
21948292
|
2 |
8.008 |
2011 |
|
The obesity paradox in heart failure: accepting reality and making rational decisions.
|
Clin Pharmacol Ther
21654743
|
16 |
7.266 |
2011 |
|
Revisiting the obesity paradox in heart failure: new insights?
|
Eur J Heart Fail
21262928
|
2 |
6.968 |
2011 |
|
Anaemia among patients with heart failure and preserved or reduced ejection fraction: results from the SENIORS study.
|
Eur J Heart Fail
21613429
|
25 |
6.968 |
2011 |
|
Increased 90-day mortality in patients with acute heart failure with elevated copeptin: secondary results from the Biomarkers in Acute Heart Failure (BACH) study.
|
Circ Heart Fail
21765124
|
56 |
6.286 |
2011 |
|
Clustering of 37 circulating biomarkers by exploratory factor analysis in patients following complicated acute myocardial infarction.
|
Int J Cardiol
22197217
|
14 |
6.189 |
2011 |
|
Furosemide induces mortality in a rat model of chronic heart failure.
|
Int J Cardiol
21450356
|
5 |
6.189 |
2011 |
|
Metabolism and the heart: an overview of muscle, fat, and bone metabolism in heart failure.
|
Int J Cardiol
21982619
|
26 |
6.189 |
2011 |
|
Sarcopenia with limited mobility: an international consensus.
|
J Am Med Dir Assoc
21640657
|
326 |
5.775 |
2011 |
|
Identification of chronic heart failure patients with a high 12-month mortality risk using biomarkers including plasma C-terminal pro-endothelin-1.
|
PLoS One
21264211
|
16 |
4.641 |
2011 |
|
Iron deficiency predicts impaired exercise capacity in patients with systolic chronic heart failure.
|
J Card Fail
22041326
|
71 |
3.765 |
2011 |
|
A prospective study of the associations between 25-hydroxyvitamin D, sarcopenia progression and physical activity in older adults.
|
Clin Endocrinol (Oxf)
21039724
|
3 |
3.327 |
2011 |
|
Differences between bisoprolol and carvedilol in patients with chronic heart failure and chronic obstructive pulmonary disease: a randomized trial.
|
Respir Med
22015086
|
34 |
3.217 |
2011 |
|
Endothelial dysfunction of the peripheral vascular bed in the acute phase after ischemic stroke.
|
Cerebrovasc Dis
22133764
|
18 |
2.974 |
2011 |
|
Effect of beta blockade on natriuretic peptides and copeptin in elderly patients with heart failure and preserved or reduced ejection fraction: results from the CIBIS-ELD trial.
|
Clin Biochem
22155435
|
9 |
2.434 |
2011 |
|
Cardio-renal anemia syndrome.
|
Contrib Nephrol
21625123
|
4 |
1.487 |
2011 |
|
Anemia in heart failure: an overview of current concepts.
|
Future Cardiol
21174515
|
3 |
1.464 |
2011 |
|
Hormonal consequences and prognosis of chronic heart failure.
|
Curr Opin Endocrinol Diabetes Obes
21494135
|
11 |
0 |
2011 |
|
Trial of lorcaserin for weight management.
|
N Engl J Med
21158671
|
0 |
72.406 |
2010 |
|
Mid-region pro-hormone markers for diagnosis and prognosis in acute dyspnea: results from the BACH (Biomarkers in Acute Heart Failure) trial.
|
J Am Coll Cardiol
20447528
|
132 |
19.896 |
2010 |
|
Battlescarred: subgroup or selection bias?
|
J Am Coll Cardiol
20951331
|
0 |
19.896 |
2010 |
|
An overview of sarcopenia: facts and numbers on prevalence and clinical impact.
|
J Cachexia Sarcopenia Muscle
21475695
|
283 |
9.697 |
2010 |
|
Diabetes mellitus, cachexia and obesity in heart failure: rationale and design of the Studies Investigating Co-morbidities Aggravating Heart Failure (SICA-HF).
|
J Cachexia Sarcopenia Muscle
21475696
|
29 |
9.697 |
2010 |
|
The effects of a high-caloric protein-rich oral nutritional supplement in patients with chronic heart failure and cachexia on quality of life, body composition, and inflammation markers: a randomized, double-blind pilot study.
|
J Cachexia Sarcopenia Muscle
21475692
|
55 |
9.697 |
2010 |
|
Ethical guidelines for authorship and publishing in the Journal of Cachexia, Sarcopenia and Muscle.
|
J Cachexia Sarcopenia Muscle
21475697
|
86 |
9.697 |
2010 |
|
Cachexia as a major underestimated and unmet medical need: facts and numbers.
|
J Cachexia Sarcopenia Muscle
21475699
|
183 |
9.697 |
2010 |
|
Elevated levels of asymmetric dimethylarginine in chronic heart failure: a pathophysiologic link between oxygen radical load and impaired vasodilator capacity and the therapeutic effect of allopurinol.
|
Clin Pharmacol Ther
20827268
|
13 |
7.266 |
2010 |
|
Mid-regional pro-adrenomedullin as a novel predictor of mortality in patients with chronic heart failure.
|
Eur J Heart Fail
20215339
|
43 |
6.968 |
2010 |
|
Advances in understanding and treating cardiac cachexia: highlights from the 5th Cachexia Conference.
|
Int J Cardiol
20561693
|
7 |
6.189 |
2010 |
|
Absolute and functional iron deficiency in professional athletes during training and recovery.
|
Int J Cardiol
21145121
|
28 |
6.189 |
2010 |
|
The small intestine: a critical linkage in pathophysiology of cardiac cachexia.
|
Int J Cardiol
21112652
|
7 |
6.189 |
2010 |
|
Studies on bacterial endotoxin and intestinal absorption function in patients with chronic heart failure.
|
Int J Cardiol
21190739
|
78 |
6.189 |
2010 |
|
Risk stratification in patients with chronic heart failure based on metabolic-immunological, functional and haemodynamic parameters.
|
Int J Cardiol
21093941
|
7 |
6.189 |
2010 |
|
Anaemia is an independent predictor of death in patients hospitalized for acute heart failure.
|
Clin Res Cardiol
19921298
|
17 |
4.76 |
2010 |
|
Novel treatment approaches to cachexia and sarcopenia: highlights from the 5th Cachexia Conference.
|
Expert Opin Investig Drugs
20367196
|
20 |
4.03 |
2010 |
|
Losartan: the dose does it.
|
Expert Opin Pharmacother
20497092
|
0 |
3.894 |
2010 |
|
Treatment with granulocyte-macrophage colony-stimulating factor is associated with reduced indoleamine 2,3-dioxygenase activity and kynurenine pathway catabolites in patients with severe sepsis and septic shock.
|
Scand J Infect Dis
19958238
|
22 |
0 |
2010 |
|
C-terminal provasopressin (copeptin) is a strong prognostic marker in patients with heart failure after an acute myocardial infarction: results from the OPTIMAAL study.
|
Eur Heart J
19346228
|
72 |
20.212 |
2009 |
|
Prevalence, incidence, and prognostic value of anaemia in patients after an acute myocardial infarction: data from the OPTIMAAL trial.
|
Eur Heart J
19383732
|
34 |
20.212 |
2009 |
|
The influence of age and sex on disease development in a novel animal model of cardiac cachexia.
|
Int J Cardiol
19246111
|
11 |
6.189 |
2009 |
|
Natriuretic peptides and other biomarkers in chronic heart failure: from BNP, NT-proBNP, and MR-proANP to routine biochemical markers.
|
Int J Cardiol
19144431
|
18 |
6.189 |
2009 |
|
Inflammation in right ventricular dysfunction due to thromboembolic pulmonary hypertension.
|
Int J Cardiol
19411119
|
14 |
6.189 |
2009 |
|
Usefulness of minimal modelling to assess impaired insulin sensitivity in patients with chronic heart failure.
|
Int J Cardiol
19733925
|
10 |
6.189 |
2009 |
|
The relationship between tumor necrosis factor-α, brain natriuretic peptide and atrial natriuretic peptide in patients with chronic heart failure.
|
Int J Cardiol
19155075
|
18 |
6.189 |
2009 |
|
Changes in serum creatinine in the first 24 hours after cardiac arrest indicate prognosis: an observational cohort study.
|
Crit Care
19874577
|
31 |
5.358 |
2009 |
|
Statins for heart failure: still caught in no man's land?
|
Clin Sci (Lond)
18973470
|
1 |
4.936 |
2009 |
|
Leukocyte redistribution: effects of beta blockers in patients with chronic heart failure.
|
PLoS One
19641622
|
13 |
4.687 |
2009 |
|
Exercise capacity and body composition in living-donor renal transplant recipients over time.
|
Nephrol Dial Transplant
19736242
|
11 |
4.47 |
2009 |
|
Increased indoleamine 2,3-dioxygenase (IDO) activity and elevated serum levels of tryptophan catabolites in patients with chronic kidney disease: a possible link between chronic inflammation and uraemic symptoms.
|
Nephrol Dial Transplant
19155537
|
104 |
4.47 |
2009 |
|
Nutrition in heart failure: an update.
|
Curr Opin Clin Nutr Metab Care
19474718
|
16 |
4.023 |
2009 |
|
The gut and intestinal bacteria in chronic heart failure.
|
Curr Drug Metab
19149510
|
32 |
3.896 |
2009 |
|
Overview of emerging pharmacotherapy in chronic heart failure.
|
Expert Opin Pharmacother
19606938
|
0 |
3.894 |
2009 |
|
Atorvastatin modulates Th1/Th2 response in patients with chronic heart failure.
|
J Card Fail
19643369
|
0 |
3.765 |
2009 |
|
Inflammatory biomarkers in heart failure revisited: much more than innocent bystanders.
|
Heart Fail Clin
19631179
|
35 |
2.124 |
2009 |
|
Neurohormonal activation and inflammation in chronic cardiopulmonary disease: a brief systematic review.
|
Wien Klin Wochenschr
19562289
|
11 |
0.974 |
2009 |
|
The burden of chronic obstructive pulmonary disease in patients hospitalized with heart failure.
|
Wien Klin Wochenschr
19562292
|
23 |
0.974 |
2009 |
|
Elevated TNFalpha production in whole blood in patients with severe COPD: the potential link to disease severity.
|
Wien Klin Wochenschr
19562291
|
9 |
0.974 |
2009 |
|
Biomarkers for chronic heart failure : diagnostic, prognostic, and therapeutic challenges.
|
Herz
20024637
|
10 |
0.776 |
2009 |
|
Insulin resistance in chronic heart failure.
|
J Am Coll Cardiol
18617075
|
6 |
19.896 |
2008 |
|
Cardiac cachexia: a systematic overview.
|
Pharmacol Ther
19061914
|
120 |
11.127 |
2008 |
|
Weight change with beta-blocker use: a side effect put into perspective.
|
Am J Med
18456014
|
0 |
5.55 |
2008 |
|
Erythropoietin levels in heart failure after an acute myocardial infarction: determinants, prognostic value, and the effects of captopril versus losartan.
|
Am Heart J
19081402
|
2 |
4.436 |
2008 |
|
The emerging role of the gut in chronic heart failure.
|
Curr Opin Clin Nutr Metab Care
18685461
|
48 |
4.023 |
2008 |
|
Interleukin-6 serum level assessment using a new qualitative point-of-care test in sepsis: A comparison with ELISA measurements.
|
Clin Biochem
18395522
|
10 |
2.434 |
2008 |
|
The cholesterol paradox revisited: heart failure, systemic inflammation, and beyond.
|
Heart Fail Clin
18433694
|
4 |
2.124 |
2008 |
|
Differentiating between body fat and lean mass--how should we measure obesity?
|
Nat Clin Pract Endocrinol Metab
18946485
|
4 |
0 |
2008 |
|
Secretory sphingomyelinase is upregulated in chronic heart failure: a second messenger system of immune activation relates to body composition, muscular functional capacity, and peripheral blood flow.
|
Eur Heart J
17353227
|
42 |
20.212 |
2007 |
|
Sibutramine in cardiovascular disease: is SCOUT the new STORM on the horizon?
|
Eur Heart J
17984134
|
8 |
20.212 |
2007 |
|
Altered intestinal function in patients with chronic heart failure.
|
J Am Coll Cardiol
17936155
|
193 |
19.896 |
2007 |
|
Comparison of midregional pro-atrial natriuretic peptide with N-terminal pro-B-type natriuretic peptide in predicting survival in patients with chronic heart failure.
|
J Am Coll Cardiol
17996563
|
42 |
19.896 |
2007 |
|
Prognostic utility of growth differentiation factor-15 in patients with chronic heart failure.
|
J Am Coll Cardiol
17825714
|
175 |
19.896 |
2007 |
|
Tipping the scale: heart failure, body mass index, and prognosis.
|
Circulation
17679626
|
6 |
19.309 |
2007 |
|
Uric acid as a prognostic marker in acute heart failure--new expectations from an old molecule.
|
Eur J Heart Fail
17433888
|
4 |
6.968 |
2007 |
|
Inflammatory pathways in patients with heart failure and preserved ejection fraction.
|
Int J Cardiol
17658631
|
22 |
6.189 |
2007 |
|
Fluvastatin reduces increased blood monocyte Toll-like receptor 4 expression in whole blood from patients with chronic heart failure.
|
Int J Cardiol
17383753
|
33 |
6.189 |
2007 |
|
A novel selective extracorporeal intervention in sepsis: immunoadsorption of endotoxin, interleukin 6, and complement-activating product 5a.
|
Shock
17558345
|
20 |
3.113 |
2007 |
|
The American Heart Association's Scientific Sessions 2006. Chicago, IL, November 12-15, 2006.
|
Heart Fail Monit
17487298
|
0 |
0 |
2007 |
|
Targeting the toll-system in cardiovascular sciences.
|
Recent Pat Inflamm Allergy Drug Discov
19075967
|
1 |
0 |
2007 |
|
Biomarkers for chronic heart failure.
|
Heart Fail Monit
17487296
|
2 |
0 |
2007 |
|
Obesity and the heart a weighty issue.
|
J Am Coll Cardiol
16750695
|
5 |
19.896 |
2006 |
|
Uric acid in CHF: marker or player in a metabolic disease?
|
Int J Cardiol
16844250
|
4 |
6.189 |
2006 |
|
Nutrition, metabolism, and the complex pathophysiology of cachexia in chronic heart failure.
|
Cardiovasc Res
17034772
|
66 |
5.878 |
2006 |
|
Toll-like receptor modulation in cardiovascular disease: a target for intervention?
|
Expert Opin Investig Drugs
16859390
|
1 |
4.03 |
2006 |
|
Annual meeting of the American Heart Association. Dallas, Texas, USA, 13-16 November 2005.
|
Expert Opin Investig Drugs
16634694
|
0 |
4.03 |
2006 |
|
The need for a standardized definition for cachexia in chronic illness.
|
Nat Clin Pract Endocrinol Metab
16932326
|
14 |
0 |
2006 |
|
The roles of immunity and autoimmunity in chronic heart failure.
|
Ernst Schering Res Found Workshop
16329662
|
0 |
0 |
2006 |
|
The effect of micronutrient supplementation on quality-of-life and left ventricular function in elderly patients with chronic heart failure.
|
Eur Heart J
16081469
|
91 |
20.212 |
2005 |
|
Impaired insulin sensitivity as an independent risk factor for mortality in patients with stable chronic heart failure.
|
J Am Coll Cardiol
16168285
|
89 |
19.896 |
2005 |
|
Whole blood endotoxin responsiveness in patients with chronic heart failure: the importance of serum lipoproteins.
|
Eur J Heart Fail
15921783
|
12 |
6.968 |
2005 |
|
Activation of the NF-kappaB system in peripheral blood leukocytes from patients with chronic heart failure.
|
Eur J Heart Fail
16112903
|
6 |
6.968 |
2005 |
|
Cellular endotoxin desensitization in patients with severe chronic heart failure.
|
Eur J Heart Fail
16087139
|
5 |
6.968 |
2005 |
|
The anti-CD14 antibody IC14 suppresses ex vivo endotoxin stimulated tumor necrosis factor-alpha in patients with chronic heart failure.
|
Eur J Heart Fail
16337191
|
5 |
6.968 |
2005 |
|
Statins for heart failure: at the crossroads between cholesterol reduction and pleiotropism?
|
Heart
15604317
|
6 |
6.059 |
2005 |
|
Pleiotropic effects of angiotensin-converting enzyme inhibitors and the future of cachexia therapy.
|
J Am Geriatr Soc
16274392
|
2 |
4.388 |
2005 |
|
Future prospects of anticytokine therapy in chronic heart failure.
|
Expert Opin Investig Drugs
15806710
|
6 |
4.03 |
2005 |
|
Effect of noradrenaline and isoproterenol on lipopolysaccharide-induced tumor necrosis factor-alpha production in whole blood from patients with chronic heart failure and the role of beta-adrenergic receptors.
|
Am J Cardiol
15781025
|
8 |
3.398 |
2005 |
|
The European Society of Cardiology (ESC) Annual Meeting 2005.
|
Heart Fail Monit
16234901
|
0 |
0 |
2005 |
|
Heat shock protein 70 in patients with chronic heart failure: relation to disease severity and survival.
|
Int J Cardiol
15301893
|
32 |
6.189 |
2004 |
|
Inflammatory mediators in chronic heart failure: an overview.
|
Heart
15020532
|
162 |
6.059 |
2004 |
|
Impact of levosimendan treatment on chronic heart failure.
|
Am J Cardiol
15476643
|
0 |
3.398 |
2004 |
|
Impact of body mass index on in-hospital outcomes following percutaneous coronary intervention.
|
Am J Cardiol
15566934
|
0 |
3.398 |
2004 |
|
[Immunactivation in chronic heart failure. Inflammatory mediators].
|
Z Kardiol
15085363
|
0 |
0 |
2004 |
|
Statins: a treatment option for chronic heart failure?
|
Heart Fail Monit
15772704
|
2 |
0 |
2004 |
|
The relationship between age and production of tumour necrosis factor-alpha in healthy volunteers and patients with chronic heart failure.
|
Int J Cardiol
12957752
|
7 |
6.189 |
2003 |
|
Tumour necrosis factor-alpha and the failing heart--pathophysiology and therapeutic implications.
|
Basic Res Cardiol
14685702
|
20 |
5.306 |
2003 |
|
Statins and the role of nitric oxide in chronic heart failure.
|
Heart Fail Rev
12652163
|
15 |
3.481 |
2003 |
|
The European Society of Cardiology working group on heart failure: Heart Failure Update 2003.
|
Heart Fail Monit
14976990
|
0 |
0 |
2003 |
|
Cachexia: a therapeutic approach beyond cytokine antagonism.
|
Int J Cardiol
12163222
|
16 |
6.189 |
2002 |
|
beta-blockers in heart failure--much more than heart rate reduction.
|
J Card Fail
12528089
|
0 |
3.765 |
2002 |
|
Pathophysiologic quantities of endotoxin-induced tumor necrosis factor-alpha release in whole blood from patients with chronic heart failure.
|
Am J Cardiol
12450603
|
15 |
3.398 |
2002 |
|
Effect of interleukin-10 on the production of tumor necrosis factor-alpha by peripheral blood mononuclear cells from patients with chronic heart failure.
|
Am J Cardiol
12161227
|
16 |
3.398 |
2002 |
|
Nitric oxide synthase in CHF.
|
Eur Heart J
10781358
|
0 |
20.212 |
2000 |
